ScoreWhy is Jubilant Pharmova Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.03% of over the last 5 years
2
Flat results in Mar 26
- PBT LESS OI(Q) At Rs 166.00 cr has Fallen at -15.91%
- PAT(Q) At Rs 128.69 cr has Fallen at -17.5%
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) generated negative returns of -5.03% in the last 1 year, its fall in the stock was much higher with a return of -15.53%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jubilant Pharmo for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jubilant Pharmo
-15.53%
-0.51
30.64%
Sensex
-10.21%
-0.78
13.06%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.68%
EBIT Growth (5y)
-8.03%
EBIT to Interest (avg)
3.13
Debt to EBITDA (avg)
3.27
Net Debt to Equity (avg)
0.33
Sales to Capital Employed (avg)
0.75
Tax Ratio
35.27%
Dividend Payout Ratio
102.46%
Pledged Shares
5.40%
Institutional Holding
27.52%
ROCE (avg)
8.18%
ROE (avg)
5.24%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
34
Price to Book Value
2.17
EV to EBIT
21.65
EV to EBITDA
14.08
EV to Capital Employed
1.88
EV to Sales
2.14
PEG Ratio
NA
Dividend Yield
0.52%
ROCE (Latest)
8.68%
ROE (Latest)
6.14%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 1,267.60 cr
NET SALES(Q)
Highest at Rs 2,290.00 cr
-8What is not working for the Company
PBT LESS OI(Q)
At Rs 166.00 cr has Fallen at -15.91%
PAT(Q)
At Rs 128.69 cr has Fallen at -17.5%
Loading Valuation Snapshot...
Here's what is working for Jubilant Pharmo
Net Sales - Quarterly
Highest at Rs 2,290.00 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 1,267.60 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Jubilant Pharmo
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 166.00 cr has Fallen at -15.91%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 128.69 cr has Fallen at -17.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 23.70 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
